274279
274279
Showing 1 - 30 of 274,279 results.
The Federal Reserve today named Henri A. Termeer, chief executive of Cambridge biotechnology firm Ge...
The Federal Reserve today named Henri A. Termeer, chief executive of Cambridge biotechnology firm Ge...
Photo by Bloomberg News Henri Termeer. Related Articles Genzyme tells investors it’s worth $89...
Photo by Patrick Whittemore (file) Genzyme CEO Henri Termeer Related Articles The Ticker By Staff an...
As Ceredase/Cerezyme progressed through clinical trials, Termeer advanced to CEO in 1985 and chairma...
Henri Termeer
To our shareholders Solidifying our position Genzyme had an outstanding year in 2005. Our strong fin...
MA-based biotech company Genzyme (NASDAQ: GENZ) has declared that it has got approval from FDA for a...
Henri Termeer kept his focus.
Henri Termeer
To our shareholders This is an exciting time for Genzyme. Our patient-centered approach has driven u...
Henri Termeer
"This is not a fixer-upper, this is beachfront property," Termeer, 64, said in an interview with the...
Henri Termeer joined Genzyme in 1983.
Diana C. Walsh
Genzyme head Henri Termeer is facing criticism.
Genzyme chief Henri Termeer, left, and Sanofi-Aventis Chief Executive Chris Viehbacher, right. Specu...
Genzyme Chief Executive Officer Henri Termeer. Photographer: Stephen Yang/Bloomberg Sanofi-Aventis S...
Photo by Herald files Genzyme Corp. CEO Henri Termeer and Sanofi CEO Chris Viehbacher. Related Artic...
Henri Termeer assured shareholders Wednesday. (Brian Snyder/Reuters) June 20, 2010
Henri Termeer
Henri Termeer
Photo by AP DONE DEAL: Sanofi-Aventis CEO Chris Viehbacher, left, and Genzyme chief Henri Termeer sh...
Reuters
Genzyme-Chef Henri Termeer Der Niederländer kommt wie die Antithese zum typischen US-Manager daher. ...
Henri Termeer
Henri A. Termeer March 28, 2005
Play Biotechnology - Will It Create a New Industry? Henri Termeer April 26, 2002 Business/Leadership...
Henri Termeer is CEO of Genzyme, which looked at 112 patients in its Clolar study. (David Kamerman/ ...
Recently Genzyme CEO Henri Termeer was quoted as saying he was ready to go on as much as a $600 mill...